| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |